Industry Leaders Select Resverlogix... (or important global medical markets with...)

Industry Leaders Select Resverlogix's RVX-208

Date:7/9/2008

or important global medical markets with significant unmet needs. The NexVas(TM) program is the Company's primary focus which is to develop novel small molecules that enhance ApoA-I. These vital therapies address the grievous burden of atherosclerosis and other important diseases such as acute coronary syndrome, diabetes, Alzheimer's and other vascular disorders. The Company's secondary focus is TGF-Beta Shield(TM), a program that aims to address burgeoning grievous diseases, such as cancer and fibrosis. Resverlogix Corp. trades on the Toronto Stock Exchange (TSX:RVX). For further information please visit http://www.resverlogix.com.

This news release may contain certain forward-looking statements that reflect the current views and/or expectations of Resverlogix Corp. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly. The TSX Exchange does not accept responsibility for the adequacy or accuracy of this news release.

SOURCE Resverlogix Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related biology technology :

1. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
2. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
3. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
4. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
5. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
6. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
7. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
8. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
9. Anesiva to Present at BioCenturys NewsMakers in the Biotech Industry Conference on September 6, 2007
10. BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
11. Suntech to Attend Upcoming Investor Conferences and Industry Events

Post Your Comments:

(Date:12/4/2008)...-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DC....D., has stepped down from his position as a direc...r. Lewis advised the Company that his decision to ...commitments to new leadership positions. , , ...81118/NY46990LOGO ) , , Dr. Harold Koplewic...

(Date:12/4/2008)...e-FirstCall/ -- ExonHit Therapeutics S.A.,(Altern...ny, is pleased to,announce today that it has been...strial Property) during the last edition of its "T... "Since its inception, ExonHit consistently ma...f its intellectual property and in particular from...

(Date:12/3/2008).... 3 GlaxoSmithKline,(LS... a condition relating to a,pending lawsuit in the... of,the outstanding shares of common stock of Gen...1.30 per share in cash without interest and less a...ondition to the completion of the tender offer tha...

(Date:12/3/2008)...FirstCall/ -- Advanced Life Sciences Holdings,In.... Food and Drug,Administration (FDA) has accepted...A) for cethromycin, a novel once-a-day oral antibi...nity acquired pneumonia (CAP). The FDA has,estab...hat the anticipated,target action date of the cet...

Breaking Biology Technology:Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors 2 ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 2 ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI) 3 GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 2 GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc. 3 Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia 2 Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia 3

[0] Jonathan Lewis, M.D., Ph.D. Steps Down From Delcath Systems Board of Directors [0] ExonHit is Honoured by the "Innovation Trophy" From The National Institute of Industrial Property (INPI)[0] GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc.[0] Advanced Life Sciences Announces Cethromycin NDA Accepted for Filing by FDA for the Treatment of Community Acquired Pneumonia

...rly known as Automating Peripherals, Inc., announc... API Software, Inc. is a provider of time and att...rces, productivity management, education tracking ...ations. , ,"After 20 years of evolving our produc...ting Peripherals, Inc., we decided we needed to up...

...loper of K-12 software solutions for special educa... announced their online, ASP software that streaml...ams (IEPs) and monitors the progress of children w...oduced in 16 Wisconsin school districts during 200... language therapists, physical therapists, psychol...

...oratories , a producer of active pharmaceutical in...rsenal Capital Partners . ,Arsenal, which targets ...ealthcare companies announced the acquisition, whi...in Waunakee, Wis., is the worlds largest independe...acture anticoagulants used in the prevention and t...

...gether to race the fastest cars they can build and..., scientists and technicians from Ohio State Unive...he goal is to win the $1 million dollar grand priz...nge . , ,The Defense Advanced Research Projects A...d advanced technology achievements that could lead...

Other Biology Technology:Oshkosh Truck Teams with OSU to Compete in DARPA Million Dollar Tech Derby 2 Oshkosh Truck Teams with OSU to Compete in DARPA Million Dollar Tech Derby 3

APIs New Name Reflects Companys Current Direction OASYS Online Provides Special Education Data Management Scientific Protein Laboratories Acquired by New York firm Oshkosh Truck Teams with OSU to Compete in DARPA Million Dollar Tech Derby

(Date:12/4/2008)...INIA KEY, Fla. -- If you,re looking for bonefish f...about 321,000 to choose from, and that is down sli...due to increased participation among those who are...f Miami,s Rosenstiel School of Marine and Atmosphe...efish census, in conjunction with the conservation...

(Date:12/4/2008)...reat earthquakes and destructive tsunamis over the... of another large earthquake, warns an internation...published in the Dec. 4 issue of the journal Natu..., a magnitude 9.2 in December 2004, produced the m...emory. The cause of that calamity was the rupture...

(Date:12/3/2008)...d H. Jones, deputy executive director of the Inter...ergy Outlook 2008" Dec. 9 at Rice University,s Bak...ress such questions as: Is the world facing a supp...ent? What type of post-Kyoto policy framework migh...levels, and what impact might such a policy framew...

(Date:12/3/2008)...VILLE, Fla. The wild pea pod is big and heavy, wi...f its parent plant. , And yet, like a grounded t...t manages if it has a reasonable chance of escape... the world,s largest experimental landscape devote... or other natural areas have discovered the pea a...

[0] Bonefish census reveals population holding steady [0] September 2007 Sumatran earthquakes research findings [0] 'World Energy Outlook' to be presented at Rice University Dec. 9 [0] Rooted plants move mysteriously down greenways, scientists say

...fect of the sun,s heat on weather balloons largely...tributed to a dispute over the existence of global...ale University and the National Oceanic and Atmosp...ublished in the journal Science, says that direct ...er balloon (radiosonde) probably explains the disc...

... of millions of locusts have, since Biblical times...ague" of major proportions, with the creatures des... now, it was thought that the directions of these ...inds. Now, Hebrew University of Jerusalem scientis...grasshoppers ?namely their polarization vision -- ...

...ersity of Alberta research team has discovered imp... effective treatments for pulmonary arterial hyper...e in the pulmonary arteries caused by uncontrolled...a disease that can lead to heart failure and death...that Survivin, a protein almost exclusively expres...

...chers at Harvard University have found evidence th... visual environment, dynamically adjusting its pro...g the commonplace. The scientists report in this w... that this principle of novelty-detection operates...irst for novelty begins in the eye itself," says M...

Other Biology News:Errors in the measurement of global warming corrected 2 Locusts' built-in 'surface analysis' ability directs them to fly overland 2 Researchers develop gene therapy to reverse pulmonary arterial hypertension 2 Researchers develop gene therapy to reverse pulmonary arterial hypertension 3 Retina adapts to seek the unexpected, ignore the commonplace 2

Errors in the measurement of global warming corrected Locusts' built-in 'surface analysis' ability directs them to fly overland Researchers develop gene therapy to reverse pulmonary arterial hypertension Retina adapts to seek the unexpected, ignore the commonplace

100 adhesive strips.

Homo sapiens palladin

Mouse P-Selectin/CD62P MAb (Clone 127933)

Molecular Biological Resources has extensive abilities cloning and expression of prokaryotic and eukaryotic proteins. Please contact lloconne@molbiores.com to discuss your project. Contact lloconne@

Biology Products:

ELISA Plate Sealers, 100 Pack from R&D Systems Rabbit Anti-Human PALLD Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.Rat Anti-Mouse P-Selectin / CD62P Monoclonal Antibody, Unconjugated, Clone 127933 from R&D Systems Cloning and Expression Services from Molecular Biology Resources

Industry Leaders Select Resverlogix...(or important global medical markets with...)